ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
N/A
ARIA
PubMed
32588922
PubMed Central
PMC7361514
DOI
10.1111/all.14471
Knihovny.cz E-zdroje
- MeSH
- angiotensin konvertující enzym 2 fyziologie MeSH
- bronchiální astma komplikace farmakoterapie MeSH
- COVID-19 etiologie MeSH
- lidé MeSH
- SARS-CoV-2 * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- angiotensin konvertující enzym 2 MeSH
7th Respiratory Medicine Department and Asthma Center Athens Chest Hospital Athens Greece
Akdis M Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
Allergy and Clinical Immunology Unit Centro Hospitalar e Universitário de Coimbra Coimbra Portugal
Allergy and Immunology Centre Pantai Hospital Kuala Lumpur Malaysia
Allergy and Respiratory Diseases Ospedale Policlino San Martino University of Genoa Genoa Italy
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Unit Instituto CUF Porto e Hospital CUF Porto Porto Portugal
Argentina Center for Allergy and Immunology Santa Fe Argentina
Center for Rhinology and Allergology Wiesbaden Germany
Centre for Inflammation Research Child Life and Health The University of Edinburgh Edinburgh UK
Centre for Research in Environmental Epidemiology ISGlobAL Barcelona Spain
Charité Universitätsmedizin Berlin Humboldt Universität zu Berlin Berlin Germany
CIBER Epidemiología y Salud Pública Barcelona Spain
Clinical Emergency Hospital for Children MS Curie Bucharest Romania
CNR Institute for Biomedical Research and Innovation Palermo Italy
College of Medicine and Health University of Exeter Medical School University of Exeter Exeter UK
Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China
Department of Allergy and Immunology Hospital Quironsalud Bizkaia Erandio Spain
Department of ENT Diseases Karolinska University Hospital Stockholm Sweden
Department of Geriatrics Montpellier University Hospital Montpellier France
Department of Immunoallergology Cova da Beira University Hospital Centre Covilhã Portugal
Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong Hong Kong
Department of Medicine University of Cape Town Cape Town South Africa
Department of Otorhinolaryngology Academic Medical Centers AMC Amsterdam The Netherlands
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology Head and Neck Surgery Semmelweis University Budapest Hungary
Department of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria
Department of Pediatrics Hospital Nacional de Niños San José Costa Rica
Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Pulmonary Medicine CHU Sart Tilman and GIGA I3 Research Group Liege Belgium
Department of Pulmonary Medicine Mainz University Hospital Mainz Germany
Department of Pulmonology Celal Bayar University Manisa Turkey
Department of Respiratory Medicine Ghent University Hospital Ghent Belgium
Department of Respiratory Medicine Hvidovre Hospital and University of Copenhagen Copenhagen Denmark
Department of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic
Departments of Medicine and Microbiology APC Microbiome Ireland University College Cork Cork Ireland
Director of Center of Allergy Immunology and Respiratory Diseases Santa Fe Argentina
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy immunology University of South Florida Tampa FL USA
Division of ENT Diseases CLINTEC Karolinska Institutet Stockholm Sweden
Division of Respirology Department of Medicine McMaster University Hamilton ON Canada
Division Paediatric Allergology University of Cape Town Cape Town South Africa
EA 2991 Euromov University Montpellier Montpellier France
Ecole Polytechnique Palaiseau IRBA Bretigny France
European Academy of Paediatrics Brussels Belgium
Faculdade de Medicina da Universidade do Porto Porto Portugal
Faculty of Health Sciences University of Beira Interior Covilhã Portugal
Faculty of Medicine Fundacion Jimenez Diaz CIBERES Autonoma University of Madrid Madrid Spain
Faculty of Medicine Institute of Immunology University of Coimbra Coimbra Portugal
Faculty of Public Health Medical University Sofia Sofia Bulgaria
Finnish Institute for Health and Welfare Helsinki Finland
Firestone Institute for Respiratory Health St Joseph's Healthcare Hamilton ON Canada
Fundação ProAR Federal University of Bahia and GARD WHO Planning Group Salvador Brazil
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
International Primary Care Respiratory Group IPCRG Aberdeen Scotland
IServicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
MACVIA France Montpellier France
Makerere University Lung Institute Kampala Uganda
Medical Consulting Czarlewski Levallois France
National Heart and Lung Institute Royal Brompton Hospital and Imperial College London London UK
National Hospital Organization Tokyo National Hospital Tokyo Japan
National Institute of Pneumology M Nasta Bucharest Romania
Pediatric Allergy and Immunology Unit Children's Hospital Ain Shams University Cairo Egypt
PROMISE Department University of Palermo Palermo Italy
Pulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology Pisa Italy
Quebec Heart and Lung Institute Laval University Québec City QC Canada
Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel
Rhinology Unit and Smell Clinic ENT Department Hospital Clínic Barcelona Spain
Russian National Research Medical University Named Pirogov Moscow Russia
Sachs' Children and Youth Hospital Södersjukhuset Stockholm Sweden
School of Medicine University CEU San Pablo Madrid Spain
Scientific Centre of Children's Health Under the MoH Moscow Russia
Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
Société de Pneumologie de Langue Française Espace Francophone de Pneumologie Paris France
Sotiria Hospital Athens Greece
Syrian Private University Damascus Damas Syria
Tobacco Control Research Centre Iranian Anti Tobacco Association Tehran Iran
Transylvania University Brasov Brasov Romania
Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
Universidad Nacional de Villa Maria Universidad Católica de Córdoba Córdoba Argentina
Universitat Pompeu Fabra Barcelona Spain
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Hospital 'Sv Ivan Rilski' Sofia Bulgaria
University Hospital Montpellier Montpellier France
University of Medicine and Pharmacy Hochiminh City Vietnam
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
Woolcock Emphysema Centre and Sydney Local Health District Glebe NSW Australia
Woolcock Institute of Medical Research University of Sydney Sydney NSW Australia
Zobrazit více v PubMed
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses . The species Severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5: 536–544. PubMed PMC
Bousquet J, Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement. Allergy. 2020;75: 2440–2444. 10.1111/all.14302 PubMed DOI
Wadhera RK, Wadhera P, Gaba P, et al. Variation in COVID‐19 hospitalizations and deaths across New York City boroughs. JAMA. 2020;323(21):2192. PubMed PMC
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS‐CoV‐2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574. PubMed PMC
Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid‐19: a systemic review and meta‐analysis. J Med Virol. 2020. 10.1002/jmv.25889 PubMed DOI PMC
Zhang JJ, Cao YY, Dong X, et al. Distinct characteristics of COVID‐19 patients with initial rRT‐PCR‐positive and rRT‐PCR‐negative results for SARS‐CoV‐2. Allergy. 2020;75:1809–1812. 10.1111/all.14316 PubMed DOI PMC
Dong X, Cao YY, Lu XX, et al. Eleven Faces of Coronavirus Disease 2019. Allergy. 2020;75:1699–1709. 10.1111/all.14289 PubMed DOI PMC
Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.04.006 PubMed DOI PMC
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID‐19 in the New York City area. JAMA. 2020;323(20):2052‐2059. PubMed PMC
Parodi SM, Liu VX. From Containment to Mitigation of COVID‐19 in the US. JAMA. 2020;323(15):1441. PubMed
Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory‐Confirmed Coronavirus Disease 2019 ‐ COVID‐NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458‐464. PubMed PMC
Docherty A, Harrison E, Green C, et al. Features of 16,749 hospitalised UK patients with COVID‐19 using the ISARIC WHO Clinical Characterisation Protocol. 10.1101/2020.04.23.20076042 PubMed DOI PMC
Collaborative TO, Williamson E, Walker A, et al. OpenSAFELY: factors associated with COVID‐19‐related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRIX. 2020. 10.1101/2020.05.06.20092999. https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1.full.pdf DOI
Morais‐Almeida M, Pité H, Aguiar R, Ansotegui I, Bousquet J. Asthma and the COVID‐19 pandemic: literature review. Int Allergy Immunol. 2020; 10.1159/000509057 PubMed DOI PMC
Jeon S, Ko M, Lee J, et al. Identification of antiviral drug candidates against SARS‐CoV‐2 from FDA‐approved drugs. Antimicrob Agents Chemother. 2020. 10.1128/AAC.00819-20 PubMed DOI PMC
Wu X, Nethery R, Sabath B, Braun D, Dominici F. Exposure to air pollution and COVID‐19 mortality in the United States: A nationwide cross‐sectional study. medRxiv and. BioRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.04.05.20054502v2 PubMed DOI PMC
Jackson D, Busse W, Bacharier L, et al. Association of respiratory allergy, asthma and expression of the SARS‐CoV‐2 receptor, ACE2. J Allergy Clin Immunol. 2020; 10.1164/rccm.202003-0821OC PubMed DOI PMC
Peters MC, Sajuthi S, Deford P, et al. COVID‐19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020. 10.1164/rccm.202003-0821OC PubMed DOI PMC
Sajuthi S, DeFord P, Jakcson N, et al. Type 2 and interferon inflammation strongly regulate SARS‐CoV‐2 related gene expression in the airway epithelium. bioRxiv. 2020. 10.1101/2020.04.09.034454 PubMed DOI PMC